DAFTAR PUSTAKA

1. Ama, Faisol. Masalah Kanker Payudara dan pemecahannya. Majalah

Kesehatan Masyarakat Indonesia. Tahun XIX. Nomor 1 Maret. Jakarta.
2. Roche. Kanker payudara. [online] 2010. [cited 2011 august 19]: available
from: http://www.pharmaceuticals.org/kankerpayudara.pdf
3. Bernik, Stephanie F. Breast Cancer: What Every Women Should Know,
[online]
2007.
[cited
2001
August
19]:
Available
from:
http://www.thehealingproject.org
4.

Faisal, A. Kanker Payudara Serang Perempuan Usia Muda. [online] 2010.

[cited
2011
August
19]:
available
from:
http://www.unhas.ac.id/humas/kankerpayudaraserangperempuan.htm

5. Pusat Komunikasi Publik Sekjen Depkes. Jika Tidak Dikendalkan 26 juta

Orang di Dunia Menderita Kanker.[online] 2008.[cited 2011 August 19]
6. Adam R, Aloia T, Krissat J, Bralet M, Paule B, Giacchetti S, et al. Is liver
resection justified for patients with hepatic metastases from breast cancer?
Ann Surg. 2006;244(6):897907.
7. Berthold F, Colin R. Markers of Bone Remodeling in Metastatic Bone
Disease. The Journal of Clinical Endocrinology & Metabolism Vol. 88, No.
11 5059-5075
8. Tjindarbumi. Diagnosis dan Pencegahan Kanker Payudara, Kursus Singkat
Deteksi Dini dan Pencegahan Kanker. 6-8 November. FKC.II-POI. Jakarta,
2005.
9. Breien O, Horgan P et all. CA15-3: a reliable indicator of metastatic bone
disease in breast cancer patients. Annals of the Royal College of Surgeons of
England (1992) vol. 74, 9-12
10. Mahindocht K., Soheila N.Serum CA 15 -3 measurement in breast cancer
patients before and after mastectomy . Arch Iranian med. 2005
11. Berthold F, Colin R. Markers of Bone Remodeling in Metastatic Bone
Disease. The Journal of Clinical Endocrinology & Metabolism Vol. 88, No.
11 5059-5075
12. Dasen W. Buku Ajar Onkologi Klinis. Jakarta. Balai Penerbit FKUI. 2008.
Hal. 366.

iv

13. Parkway Cancer Centre, apakah kanker payudara itu?,2011,

http://www.parkwaycancercentre.com/bahasa-indonesia/about-cancer/typesof-cancer, Diakses 05 September 2012
14. Hortobagyi G, Salazar JdlG, Pritchard K. The global breast cancer burden:
variations in epidemiology and survival Clin Breast Cancer. 2005;6:391401.\
15. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. Cancer J Clin
2012;62(10).
16. News
Medical,
breast
cancer
epidemiologi.http://www.newsmedical.net/health/Breast-Cancer-Epidemiology-%28Indonesian%29.aspx.
diakses 16 November 2011.
17. Desan,Wan.2011.Buku Ajar Onkologi Klinis.Balai Penerbit FKUI.Jakarta.
Hal: 370-373.
18. Indisari, R, Henry S, Djoko H, 2005. Faktor-faktor Risiko yang berpengaruh
terhadap Kejadian Kanker Payudara Wanita, dengan tanggal 29 Desember
2011. http://eprinta.undip.ac.id/5248/I/Rini_Indarti.pdf
19. DeVita, Vincent T., Hellman, Samuel, Steven., Cancer: Principles &
Practice of oncology, 7th Edition, Copyright A2005 Lippincott Williams &
Wilkins.
20. Byung-Ho Nam, Sun Young Kim, Hye-Suk Han, Youngmee kwon, Keun
Seok Lee, Tae Hyun Kim, Jungsil Ro, Breast Cancer subtypes and survival in
patients with brain metasrtases Breast Cancer Research 2008,
10:1186/bcr1870.
21. Eric L. Chang, Simon Lo, Diognosis and management of Central Nervous
System Metastases from Breast Cabcer, The Oncologist, vol. 8, no. 5, 389410, oktober 2003
22. Wadasadawala T, Gupta S, Bagul V, Patil N,. Brain metastases from Breast
cancer: management appoarch. J Can Res Ther 2001
23. Mustafa Y,* et al. Relationship between bone scintigraphy and tumor markers
in patients with breast cancer. Annals of Nuclear Medicine Vol. 18, No.
6,501505, 2004
24. Manfred Schmitt1. Circulating tumor cells in blood of primary breast cancer
patients assessed by a novel RT-PCR test kit and comparison with statusof
bone marrow-disseminated tumor cells. Breast Cancer Research 2009,11:109

iv

25. Sujatha Muthuswamy. Clinical significance of cancer antigen, CA 15.3 in

breast cancer. Indian J Med Sci [serial online] 2000 [cited 2009 Nov
7];54:442-7.
26. Vildan Yasasever, Maktav. Utility of CA 15-3 and CEA in monitoring
breastcancer patients with bone metastases: Special emphasis on spikin
phenomen. Clinical BiochemistryVolume 30, Issue 1, February 2007, Pages
53-5
27. Shigesawa, Toshirou MD. Bone Metastasis Detected by FDG PET in a
Patient With Breast Cancer and Fibrous Dysplasia. Aug 2005 - Volume 30
Issue 8 - pp 571-573
28. Harningsih, Sri. Waspada Kanker Payudara. 2010. Augst. From :
http://www.pesankesehatan.com/waspadakankerpayudara.pdf.
29. Kristine E.C and Armando E.C. breast Cancer. In: Berek 7 Novaks
Gynecology 14th Ed. Standford, California: Lippincolt Williams 7 Wilkins;
2007.p.!.606-27.
30. Ramli, H. Muchlis. Kanker Payudara. Dalam: Reksopardjo Soelarto,
Pusponegoro Aiyoo D, Kartono D, Hutagalung E.U, Sumardi R, et all, eds.
Kumpulan Kuliah Ilmu Bedah. Jakarta: Binarupa Aksara; 1995.p.342-63.
31. Ford D., and Easton D.F. The Genetics of Breast and Ovarian Cancer. British
Journal of Cancer, 72:805-812.
32. Sagung Seto. Panduan Penatalaksanaan Kanker Payudara.Dalam : Manuaba
Tjakra Wibawa, editor. Panduan Penatalaksanaan kanker Solid PERABOI
2010. Jakarta:; 2010.p.17-47.
33. Syamsuhidayat R, Wim De Jong. Buku ilmu bedah, edisi 2. Jakarta; ECG,
2006.
34. Sylvia Anderson Price, Lorraine Me Carty Wilson. Patofisiologi. Vol. 2. Edisi
S6. Jakarta; ECG 2006
35. Kumar, Vinay, dkk. Editor. Buku Ajar Patologi Robbins. Edisi 7. Cet.1. buku
kedokteran ECG. Jakarta: 2007. Hal. 794-801
36. Pane, M. Epidemiologi Kanker Payudara. News Medical Update on. 15 th
March 2012, available at: http://www.breast.cancer.epiddemiology.aspx.htm.
37. Hariani, Netti. Anatomi dan Fisiologi Payudara (Mammae). Update on 8 th july
2008, available at: http://anatomi-dan-fisiologi-payudara-mammae3.html

iv

38. Pierce A Grae, Neil R Boerly. At a Glance ilmu bedah. Edisi 3. Jakarta;
Erlangga 2006.
39. Davey, Patrick, 2006. Kanker Payudara. Dalam: Davey, Patrick, ed. At a
Glance Medicine. Jakarta : Penerbit Erlangga
40. Seymour Schwart, MD. Intisari prinsip-prinsip ilmu bedah. Edisi 6. Jakarta;
ECG, 2006.

iv